CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
93 hedge funds and large institutions have $132M invested in Cascadian Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
15% less capital invested
Capital invested by funds: $155M → $132M (-$23.5M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
93
Holding in Top 10
1
Calls
$513K
Puts
$168K
Top Buyers
| 1 | +$5.41M | |
| 2 | +$2.7M | |
| 3 | +$1.84M | |
| 4 |
DS
DRW Securities
Chicago,
Illinois
|
+$1.14M |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$864K |
Top Sellers
| 1 | -$3.08M | |
| 2 | -$2.87M | |
| 3 | -$2.85M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$2.58M |
| 5 |
QF
QVT Financial
New York
|
-$1.68M |